Thike AA - Search Results

1

Molecular insights into paediatric breast fibroepithelial tumours.

Tay TKY, Guan P, Loke BN, Nasir NDM, Rajasegaran V, Thike AA, Lian D, Chang KTE, Teh BT, Ng CCY, Tan PH. Tay TKY, et al. Among authors: thike aa. Histopathology. 2018 Nov;73(5):809-818. doi: 10.1111/his.13701. Epub 2018 Aug 22. Histopathology. 2018. PMID: 29969836

2

Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters.

Thike AA, Chng MJ, Fook-Chong S, Tan PH. Thike AA, et al. Pathology. 2001 Feb;33(1):21-5. Pathology. 2001. PMID: 11280603

3

Mucin extravasation in breast core biopsies--clinical significance and outcome correlation.

Begum SM, Jara-Lazaro AR, Thike AA, Tse GM, Wong JS, Ho JT, Tan PH. Begum SM, et al. Among authors: thike aa. Histopathology. 2009 Nov;55(5):609-17. doi: 10.1111/j.1365-2559.2009.03422.x. Histopathology. 2009. PMID: 19912367

4

Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.

Yu YN, Yip GW, Tan PH, Thike AA, Matsumoto K, Tsujimoto M, Bay BH. Yu YN, et al. Among authors: thike aa. Int J Oncol. 2010 Aug;37(2):483-92. Int J Oncol. 2010. PMID: 20596676

5

Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms.

Jara-Lazaro AR, Akhilesh M, Thike AA, Lui PC, Tse GM, Tan PH. Jara-Lazaro AR, et al. Among authors: thike aa. Histopathology. 2010 Aug;57(2):220-32. doi: 10.1111/j.1365-2559.2010.03607.x. Histopathology. 2010. PMID: 20716164

6

Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.

Lwin ZM, Guo C, Salim A, Yip GW, Chew FT, Nan J, Thike AA, Tan PH, Bay BH. Lwin ZM, et al. Among authors: thike aa. Mod Pathol. 2010 Dec;23(12):1559-66. doi: 10.1038/modpathol.2010.173. Epub 2010 Sep 10. Mod Pathol. 2010. PMID: 20834237 Free article.

7

Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression.

Ang MK, Ooi AS, Thike AA, Tan P, Zhang Z, Dykema K, Furge K, Teh BT, Tan PH. Ang MK, et al. Among authors: thike aa. Breast Cancer Res Treat. 2011 Sep;129(2):319-29. doi: 10.1007/s10549-010-1204-5. Epub 2010 Oct 14. Breast Cancer Res Treat. 2011. PMID: 20945089

8

Expression of heparan sulfate in gastric carcinoma and its correlation with clinicopathological features and patient survival.

Lo SL, Thike AA, Tan SY, Lim TK, Tan IB, Choo SP, Tan PH, Bay BH, Yip GW. Lo SL, et al. Among authors: thike aa. J Clin Pathol. 2011 Feb;64(2):153-8. doi: 10.1136/jcp.2010.087478. Epub 2010 Dec 19. J Clin Pathol. 2011. PMID: 21169639

9

Therapeutic targets in triple negative breast cancer - where are we now?

Teng YH, Thike AA, Wong NS, Tan PH. Teng YH, et al. Among authors: thike aa. Recent Pat Anticancer Drug Discov. 2011 May;6(2):196-209. doi: 10.2174/157489211795328521. Recent Pat Anticancer Drug Discov. 2011. PMID: 21247402 Review.

10

Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy.

Teng YH, Tan WJ, Thike AA, Cheok PY, Tse GM, Wong NS, Yip GW, Bay BH, Tan PH. Teng YH, et al. Among authors: thike aa. Breast Cancer Res. 2011 Apr 1;13(2):R35. doi: 10.1186/bcr2857. Breast Cancer Res. 2011. PMID: 21457545 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters